Antirheumatic Disease Therapies for the Treatment of COVID-19: A Systematic Review and Meta-Analysis.
Michael S PutmanYu Pei Eugenia ChockHerman H Y TamAlfred Hyoungju KimSebastian Eduardo SattuiFrancis BerenbaumMaria I DanilaPeter KorstenCatalina Sanchez-AlvarezJeffrey A SparksLaura C CoatesCandace PalmerleeAndrea PeirceArundathi JayatillekeSindhu R JohnsonAdam KilianJean W LiewLarry J ProkopM Hassan MuradPhilip C RobinsonZachary S WallaceAli Duarte Garcianull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2020)
In this systematic review and meta-analysis, hydroxychloroquine use was not associated with benefit or harm regarding COVID-19 mortality. The evidence supporting the effect of other antirheumatic disease therapies in COVID-19 is currently inconclusive.